| Income Statement |
| Total Revenue | 121.50M |
|
| Revenues (USD) | 121.50M |
| Cost of Revenue | 82.40M |
| Gross Profit | 39.10M |
| Operating Expenses | 31.90M |
| Research and Development Expense | 9.40M |
| Selling, General and Administrative Expense | 22.50M |
| Operating Income | 7.20M |
| Income Tax Expense | 100.00K |
| Net Income | 7.10M |
| Net Income Common Stock | 7.10M |
| Net Income Common Stock (USD) | 7.10M |
| Consolidated Income | 7.10M |
| Earnings per Basic Share | 0.27 |
| Earnings per Basic Share (USD) | 0.27 |
| Earnings per Diluted Share | 0.27 |
| Earning Before Interest & Taxes (EBIT) | 7.20M |
| Earning Before Interest & Taxes (USD) | 7.20M |
| Weighted Average Shares | 25.84M |
| Weighted Average Shares Diluted | 26.35M |
| Balance Sheet |
| Cash and Equivalents | 304.80M |
| Cash and Equivalents (USD) | 304.80M |
| Investments | 423.90M |
| Trade and Non-Trade Receivables | 801.60M |
| Total Assets | 2.06B |
| Total Liabilities | 1.61B |
| Accumulated Retained Earnings (Deficit) | -1.21B |
| Accumulated Other Comprehensive Income | -600.00K |
| Shareholders Equity | 448.70M |
| Shareholders Equity (USD) | 448.70M |
| Deferred Revenue | 615.30M |
| Goodwill and Intangible Assets | 55.90M |
| Trade and Non-Trade Payables | 356.30M |
| Cash Flow |
| Net Cash Flow from Financing | 3.70M |
| Net Cash Flow / Change in Cash & Cash Equivalents | 54.70M |
| Capital Expenditure | -3.20M |
| Net Cash Flow - Business Acquisitions and Disposals | 25.00M |
| Issuance (Purchase) of Equity Shares | 1000.00K |
| Net Cash Flow from Investing | 42.50M |
| Net Cash Flow - Investment Acquisitions and Disposals | 20.70M |
| Net Cash Flow from Operations | 8.50M |